Search

Your search keyword '"Robert P. Chilcott"' showing total 95 results

Search Constraints

Start Over You searched for: Author "Robert P. Chilcott" Remove constraint Author: "Robert P. Chilcott"
95 results on '"Robert P. Chilcott"'

Search Results

1. Profiling the vendors of COVID‐19 related product on the Darknet: An observational study

2. Sebomic identification of sex- and ethnicity-specific variations in residual skin surface components (RSSC) for bio-monitoring or forensic applications

3. Application of sebomics for the analysis of residual skin surface components to detect potential biomarkers of type-1 diabetes mellitus

4. Eyeing up the Future of the Pupillary Light Reflex in Neurodiagnostics

5. Chest Compressions and Defibrillation as Aerosolgenerating Procedures

6. Experiences of personal protective equipment and reasons for non-compliance

7. Quantifying the Risk to Health Care Workers of Cough as an Aerosol Generating Event in an Ambulance Setting: A Research Report

8. Volunteer trials of a novel improvised dry decontamination protocol for use during mass casualty incidents as part of the UK'S Initial Operational Response (IOR).

9. Evaluation of absorbent materials for use as ad hoc dry decontaminants during mass casualty incidents as part of the UK's Initial Operational Response (IOR).

10. A fatal case-report of barium chloride toxicity

13. Decontamination and Management of Contaminated Hair following a CBRN or HazMat Incident

14. SARS-CoV-2: Characterisation and Mitigation of Risks Associated with Aerosol Generating Procedures (AGPs) in Dental Practices

15. Optimization of Nonambulant Mass Casualty Decontamination Protocols as Part of an Initial or Specialist Operational Response to Chemical Incidents

16. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant

17. Efficacy of Different Hair and Skin Decontamination Strategies with Identification of Associated Hazards to First Responders

19. The percutaneous toxicokinetics of Sulphur mustard in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant

20. Development of haemostatic decontaminants for treatment of wounds contaminated with chemical warfare agents. 3: Evaluation of in vitro topical decontamination efficacy using damaged skin

21. Evaluation of a new topical skin protectant (RD1433) for the prevention and treatment of incontinence-associated dermatitis

22. Mass Casualty Decontamination in the United States: An Online Survey of Current Practice

23. Further studies of the efficacy of military, commercial and novel skin decontaminants against the chemical warfare agents sulphur Mustard, Soman and VX

24. Hybrid in vitro diffusion cell for simultaneous evaluation of hair and skin decontamination: temporal distribution of chemical contaminants

25. Preliminary evaluation of military, commercial and novel skin decontamination products against a chemical warfare agent simulant (methyl salicylate)

26. Octodrine: New Questions and Challenges in Sport Supplements

27. Optimisation of a dosing regime for a topical skin protectant (barrier cream)

28. Evaluation of US Federal Guidelines (Primary Response Incident Scene Management [PRISM]) for Mass Decontamination of Casualties During the Initial Operational Response to a Chemical Incident

29. The percutaneous absorption of soman in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant

30. Managing mass casualties and decontamination

31. Recent advances to address European Union Health Security from cross border chemical health threats

32. Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 2: Evaluation ofin vitrotopical decontamination efficacy using undamaged skin

33. Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1: Evaluation ofin vitroclotting efficacy in the presence of certain contaminants

34. Effect of ethnicity, gender and age on the amount and composition of residual skin surface components derived from sebum, sweat and epidermal lipids

35. Evaluation of absorbent materials for use as ad hoc dry decontaminants during mass casualty incidents as part of the UK's Initial Operational Response (IOR)

36. Volunteer trials of a novel improvised dry decontamination protocol for use during mass casualty incidents as part of the UK'S Initial Operational Response (IOR)

37. The percutaneous toxicokinetics of Sulphur mustard in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant

38. In vivodecontamination of the nerve agent VX using the domestic swine model

39. Pharmacokinetics of acetylcholinesterase reactivator K203 and consequent evaluation of low molecular weight antioxidants/markers of oxidative stress

41. UK’s initial operational response and specialist operational response to CBRN and HazMat incidents: a primer on decontamination protocols for healthcare professionals

42. Comparative Analysis of Showering Protocols for Mass-Casualty Decontamination

43. The skin reservoir of sulphur mustard

44. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro

45. Closed Cup Vapor Systems in Percutaneous Exposure Studies: What is the Dose?

46. Evaluation of a Barrier Cream against the Chemical Warfare Agent VX using the Domestic White Pig

47. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig

48. Transepidermal Water Loss Does Not Correlate with Skin Barrier Function In Vitro

49. Evaluation of Barrier Creams against Sulphur Mustard

50. Hair analysis for the detection of drug use-is there potential for evasion?

Catalog

Books, media, physical & digital resources